James N. Livingston
First Flight Venture Center(US)NovaTarg Therapeutics (United States)(US)
Publications by Year
Research Areas
Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism, Pancreatic function and diabetes, Diabetes Treatment and Management, Adipokines, Inflammation, and Metabolic Diseases
Most-Cited Works
- → Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity(1988)370 cited
- → Distribution of insulin receptor-like immunoreactivity in the rat forebrain(1989)297 cited
- → Small-Molecule Ghrelin Receptor Antagonists Improve Glucose Tolerance, Suppress Appetite, and Promote Weight Loss(2007)227 cited
- → Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway(1998)218 cited
- → Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitus(1987)179 cited
- → Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity(2007)